TOVESANGENE PARVEC
UNII 2XJ94NG3WX

Substance Identification & Data

This profile provides standardized clinical and technical data for Tovesangene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2XJ94NG3WX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3064917-67-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2XJ94NG3WX
CAS Registry Number
3064917-67-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TOVESANGENE PARVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
13992
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tovesangene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TOVESANGENE PARVEC

Common Names & Synonyms

RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 9 (RAAV9) VECTOR ENCODING A MINIATURISED VERSION OF HUMAN SHANK3 (SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 3, PROLINE-RICH SYNAPSE-ASSOCIATED PROTEIN 2 (PROSAP2); CORRESPONDING TO AMINO ACIDS 537-782, 1347-1806 OF THE FULL-LENGTH SHANK3 PROTEIN, M1>ADDED) PRECEDED BY A KOZAK SEQUENCE WITH EXPRESSION UNDER CONTROL OF THE HUMAN SYNAPSIN I PROMOTER, A WOODCHUCK HEPATITIS VIRUS POST-TRANSCRIPTIONAL REGULATORY ELEMENT (WPRE) AND A HUMAN GROWTH HORMONE (HGH) POLYADENYLATION SIGNAL; FLANKED BY AAV2 INVERTED TERMINAL REPEATS (ITRS)
TOVESANGENE PARVEC [INN]

Technical Codes

JAG-201